INSP Inspire Medical Systems Inc.

🔔End of Day Trading Update🔔 📅Wednesday 2/11/2022📅 🟢Bullish Activity🟢 $CRL Shares are gapping up this morning after the provider of drug discovery, non-clinical development and safety testing services reported Q3 earnings of $2.63 per share $0.13 beat on revenue that rose 10.4% YOY to $989.16M above the $970.43M consensus. The company raised full-year 2022 guidance as EPS is now expected to come in a range of $10.80-10.95 from $10.70-10.95 and revenue growth is now expected to be +10-11% from +9-11%. Option volume is relatively light with the November 18th 140.00 put being the highest volume contract. $INSP Also to the upside after the medical technology company reported a Q3 loss of $0.60 per share $0.19 beat on revenue that rose 76.4% YOY to $109.2M above the $94.61M consensus. The company issued upside guidance as full-year 2022 revenue is expected to come in a range of $384-388M above the $361.29M consensus. Shares are trading above the 200 day SMA for the first time since